Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation. - Stirrup, OT; Asboe, D; Pozniak, A; Sabin, CA; Gilson, R; Mackie, NE; Tostevin, A; Hill, T; Dunn, DT; Chadwick, David; Churchill, Duncan; Clark, Duncan; et al. (HIV Medicine, 2020)